Fibrinolytic activity without fibrinogenolysis during long-distance racing in horses.

The study investigates the effects of long-distance racing on fibrinolytic activity in horses and human, with specific emphasis on how differing levels of strain influence the body’s clot dissolving mechanism without causing fibrinogen degradation. Additionally, it examines variations in fibrinogen A alpha-chain heterogeneities in both species.

Objective and Participants

• The study evaluated 14 horses and 2 human runners who participated in a 157-km endurance run.
• The researchers aimed to understand the body’s fibrinolytic activity (the process of dissolving blood clots) during intense exercise, and whether it causes fibrinogen degradation (breaking down of a protein that helps form blood clots).

Methodology

• The fibrin monomer samples from horses and humans were examined using two types of gel electrophoresis methods – two-dimensional gel electrophoresis and sodium dodecyl sulfate polyacrylamide gel electrophoresis. These advanced techniques enable analysis of proteins through separation based on molecular weight and electric charge.
• This led to the discovery of two distinct types of horse Beta-chain that had higher molecular weights and varying electric charges compared to the human beta-chain.
• The study also found that horse alpha-chains also exhibited higher molecular weights than the human variant, though they showed similar heterogeneities in alpha-chain.

Data Analysis

• Upon examination, it was observed that the speed at which clots dissolved (measured using Euglobulin Lysis Time or ELT) in the horses hastened at fairly consistent rates while racing (52% of control at 44 km). On the other hand, the time it took for plasma clots to dissolve (measured using Plasma Clot Lysis Time or PCLT) fell progressively during the race (30% of control at finish).
• When comparing horses and humans at the finish line, the researchers discovered similar readings for ELTs and PCLTs.

Conclusions

• The study concluded that despite an extended period of heightened fibrinolytic activity brought about by the strenuous activity of long-distance racing, there was no evidence of an increase in the breaking down of A alpha-chain, a part of the fibrinogen protein.
• It also found that the continuous stimuli of the fibrinolytic enzyme system (plasmin) aren’t responsible for the variations observed in fibrinogen A alpha-chain heterogeneities among horses and humans.
• The research additionally highlighted the efficacy of horses as model organisms for studying exercise-induced fibrinolysis – a useful finding for future physiological studies.